Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

<p>Abstract</p> <p>Background</p> <p>Inhaled corticosteroids are the recommended first-line treatment for asthma but adherence to therapy is suboptimal. The objectives of this study were to compare the efficacy and safety of once-daily (OD) evening and twice-daily (BD)...

Full description

Bibliographic Details
Main Authors:	Woodcock Ashley, Bleecker Eugene R, Busse William W, Lötvall Jan, Snowise Neil G, Frith Lucy, Jacques Loretta, Haumann Brett, Bateman Eric D
Format:	Article
Language:	English
Published:	BMC 2011-12-01
Series:	Respiratory Research
Subjects:	Asthma fluticasone furoate inhaled corticosteroid once daily efficacy safety
Online Access:	http://respiratory-research.com/content/12/1/160

Similar Items

Real-world efficacy and problems of once-daily use of inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) in Japanese patients with asthma
by: Akira Umeda, et al.
Published: (2019-01-01)

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial
by: Jacques Loretta, et al.
Published: (2011-10-01)

Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial
by: Furuhashi K, et al.
Published: (2019-09-01)

Fluticasone furoate: A new intranasal corticosteroid
by: R Kumar, et al.
Published: (2012-01-01)

In vitro Antibacterial Activity of Mometasone Furoate, Fluticasone Propionate and Fluticasone Furoate Nasal Preparations Against Streptococcus pneumoniae, Hemophilus influenzae, Streptococcus viridans, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli
by: Philip Lance A. Liu, et al.
Published: (2010-06-01)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
by: Maria Doulaptsi, et al.
Published: (2021-09-01)

A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD
by: Bhatt SP, et al.
Published: (2017-01-01)

Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis
by: Nandish Chennakeshavaraju, et al.
Published: (2020-01-01)

A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis of children with asthma
by: Philippe Bareille, et al.
Published: (2020-02-01)

Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy
by: Albertson TE, et al.
Published: (2016-12-01)

Comparison of Fluticasone Furoate Nasal Spray Versus Combined Oral Anti-Histamine and Anti-Leukotriene Therapy in Allergic Rhinitis
by: Junaid Shahzad, et al.
Published: (2018-06-01)

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk
by: Covelli H, et al.
Published: (2015-12-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy
by: Lal C, et al.
Published: (2016-12-01)

Safety and efficacy of fluticasone furoate nasal spray in Japanese children 2 to <15 years of age with perennial allergic rhinitis: A multicentre, open-label trial
by: Kimihiro Okubo, et al.
Published: (2015-01-01)

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study
by: Peter R. Bremner, et al.
Published: (2018-01-01)

Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and COPD in UK Primary Care: Retrospective Cohort Study
by: Daniel Dedman, et al.
Published: (2019-04-01)

Efficacy and Safety of Fluticasone Furoate Nasal Spray in Japanese Children with Perennial Allergic Rhinitis: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
by: Kimihiro Okubo, et al.
Published: (2014-01-01)

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS
by: Vallejo-Aparicio LA, et al.
Published: (2018-09-01)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
by: Roberto W. Dal Negro, et al.
Published: (2018-06-01)

Comparison of Mometasone Furoate Monohydrate (Nasonex) and Fluticasone Propionate (Flixonase) Nasal Sprays in the Treatment of Dust Mite-sensitive Children with Perennial Allergic Rhinitis
by: Ka-Kit Mak, et al.
Published: (2013-08-01)

Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database
by: Ryo Atsuta, et al.
Published: (2018-10-01)

Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol
by: Molino A, et al.
Published: (2018-06-01)

Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective
by: Schroeder M, et al.
Published: (2020-07-01)

Effects of Exenatide Twice Daily and Once Weekly on Weight Loss
by: Patel, Rajal, et al.
Published: (2013)

Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study
by: Henrik Watz, et al.
Published: (2020-04-01)

Conversion from Twice-Daily to Once-Daily Tacrolimus Improves Graft Function but has no Influence on Proteinuria in Renal Transplant Recipients
by: Basic-Jukic Nikolina, et al.
Published: (2016-12-01)

In Vitro Analysis of Nine MicroRNAs in CD8+ T Cells of Asthmatic Patients and the Effects of Two FDA-approved Drugs
by: Mohsen Badalzadeh, et al.
Published: (2019-08-01)

Efficacy and toxicity of once versus twice daily regimens of amikacin in febrile neutropenic pediatric cancer patients
by: Reda Abd-Elfattah, et al.
Published: (2017-03-01)

The IMPACT Study – Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population
by: Kato M, et al.
Published: (2019-12-01)

Efficacy of Fluticasone and Oxymetazoline as the Treatment for Allergic Rhinitis
by: Prithpal S. Matreja, et al.
Published: (2012-02-01)

Effects of Late Conversion from Twice-Daily to Once-Daily Slow Release Tacrolimus on the Insulin Resistance Indexes in Kidney Transplant Patients
by: Valeria Cademartori, et al.
Published: (2021-02-01)

Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design
by: Sally Worsley, et al.
Published: (2019-11-01)

New possibilities of pharmacotherapy for chronic obstructive pulmonary disease
by: A. I. Sinopalnikov, et al.
Published: (2018-10-01)

Treatment Evaluation with Mometasone Furoate, Alone or in Combination with Desloratadine/ Montelukast in Moderate Severe Allergic Rhinitis
by: Florincescu-Gheorghe Nona-Aura, et al.
Published: (2014-06-01)

Effects of Salmeterol and Fluticasone Propionate Combination versus Fluticasone Propionate on Airway Function and Eosinophilic Inflammation in Mild Asthma
by: Makoto Hoshino, et al.
Published: (2009-01-01)

Performance of dairy cows milked twice daily at contrasting intervals
by: B. Rémond, et al.
Published: (2009-01-01)

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
by: Donohue JF, et al.
Published: (2019-12-01)

Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
by: Louis-Philippe Boulet, et al.
Published: (2000-01-01)

Mometasone furoate in the treatment of mild, moderate, or severe persistent allergic rhinitis: a non-inferiority study (PUMA)
by: Martti Anton Antila, et al.

Cannot write session to /tmp/vufind_sessions/sess_1smfpms1i0np5dmtrar5eitpnu